Sage Journals: Discover world-class research

Retricted access

Case report

First published 2019-6

Daratumumab,pomalidomide,and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement

Justin R Arnall, Saad Z Usmani, Hawawu Adamu [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2022-3

Real-world treatment patterns in relapsed/refractory multiple myeloma: Clinical and economic outcomes in patients treated with pomalidomide or daratumumab

Joshua Richter, Vamshi Ruthwik Anupindi, Jason Yeaw [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2021-1

A pharmacist’s review of the treatment of systemic light chain amyloidosis

David M. Hughes, Andrew Staron, Vaishali Sanchorawala

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2025-4

Change in hair texture with the use of pomalidomide for multiple myeloma: From straight to curly phenotype

Annam Zahid, Constantin A. Dasanu

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2020

Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma

Maximilian Johannes Steinhardt, Xiang Zhou, Franziska Krummenast [...]

International Journal of Immunopathology and Pharmacology

Retricted access

Review article

First published 2023-1

Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myeloma

Bhavesh Shah, Joy Gray, Ivo Abraham [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2016-4

Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease

Emily Ashjian, Kimberly Redic

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2024-4

Selinexor for the treatment of patients with relapsed or refractory multiple myeloma

Anum Babar, Maham Babar, Hina Zubair [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2025-10

Using bispecific antibodies in a patient with peritoneal dialysis for relapsed multiple myeloma

Heng Jiang, Yagya Ahlawat, Amir Steinberg

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

Immunotherapy in myeloma: how far have we come?

Laurens E. Franssen, Tuna Mutis, Henk M. Lokhorst [...]

Therapeutic Advances in Hematology

Search results